Clinical Trials Directory

Trials / Completed

CompletedNCT04084561

Risk Communication in African American Smokers

Nicotine Dependence and Lung Cancer Genetics in African Americans

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
166 (actual)
Sponsor
Temple University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Participants will be given hypothetical personalized genetic risk results and ask to think about how they might respond to such information if they actually received such results.

Detailed description

The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Smokers will be randomized to receive hypothetical information about their genetic status and consider how they think they would respond if such results were actually presented to them. They will be randomly assigned to receive one of four sets of hypothetical genetic results: 1) High risk of lung cancer and high genetic African ancestry, 2) High risk of lung cancer and low genetic African ancestry, 3) Low risk of lung cancer and high genetic African ancestry, or 4) Low risk of lung cancer and low genetic African ancestry. After being given this hypothetical information, participants will complete brief questionnaires assessing perceived risk of lung cancer, worry about cancer, psychological distress, and motivation to quit smoking.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHRHAparticipants will be asked to consider a hypothetical scenario in which genetic test results reveal that: 1) they carry genotypes that place African American smokers at a particularly high (\~50%-80%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly high concordance with African heritage (\~90%).
BEHAVIORALLRLAparticipants will be asked to consider a scenario in which genetic test results reveal that: 1) they are at normal (\~7%-10%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly low concordance with African heritage (\~10%).
BEHAVIORALHRLAparticipants will receive "High Risk, Low Ancestry (HRLA)" hypothetical
BEHAVIORALLRHAparticipants will receive "Low Risk, High Ancestry (HRLA)" hypothetical

Timeline

Start date
2018-09-01
Primary completion
2022-04-01
Completion
2022-04-01
First posted
2019-09-10
Last updated
2023-12-18
Results posted
2023-12-18

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04084561. Inclusion in this directory is not an endorsement.